<DOC>
	<DOCNO>NCT01324999</DOCNO>
	<brief_summary>This study design assess efficacy safety tadalafil patient Sarcoidosis Associated Pulmonary Hypertension . Hypothesis : Tadalafil safe effective treat pulmonary hypertension patient Sarcoidosis</brief_summary>
	<brief_title>Tadalafil Sarcoidosis Associated Pulmonary Hypertension</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Hypertension , Pulmonary</mesh_term>
	<mesh_term>Sarcoidosis</mesh_term>
	<mesh_term>Tadalafil</mesh_term>
	<criteria>Biopsy proven sarcoidosis Mean pulmonary artery pressure &gt; 25 mmHg rest great 30 mmHg exercise right heart catheterization within 1 year prior entry study Pulmonary capillary wedge pressure ≤ 15 mmHg PVR value ≥ 3.0 Woods unit Forced vital capacity ( FVC ) &gt; 40 % predict Forced expiratory volume 1 second ( FEV1 ) &gt; 40 % predict WHO functional class II III Stable sarcoidosis treatment regimen three month prior entry study 6 minute walk distance 150450 meter Stable dose antihypertensive medication On medication treat PAH ( sildenafil , vardenafil , treprostinil , epoprostenol , iloprost , bosentan , ambrisentan ) within one month prior enrollment duration study Nonpregnant females Exercise limitation relate noncardiopulmonary reason ( e.g . arthritis ) Severe systemic hypertension &gt; 170/95 Severe systemic hypotension &lt; 90/50 History priapism Patients congestive heart failure ( left ventricular dysfunction ) LVEF &lt; 45 % echocardiogram Anticipation investigator escalation sarcoidosis treatment course study Pulmonary hypertension relate etiology sarcoidosis ( i.e . HIV , scleroderma , chronic thromboemboli ) Use within 1 month sildenafil vardenafil WHO functional class IV status Patients severe organ disease felt investigator impact survival course study Subjects liver function abnormality ( ALT AST &gt; 3 time upper limit normal screen baseline ) chronic liver disease Advanced kidney failure ( GFR &lt; 30 ml/min screen baseline ) History hypersensitivity reaction adverse effect relate tadalafil Pregnant lactate woman Concomitant use nitrate ( form ) either regularly intermittently Concomitant use potent CYP3A inhibitor ( eg , ritonavir , ketoconazole , itraconazole ) Any additional contraindication precaution specify package insert Tadalafil ( Adcirca ) list</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2014</verification_date>
	<keyword>Sarcoidosis Associated Pulmonary Hypertension</keyword>
</DOC>